GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (NAS:OGI) » Definitions » YoY EBITDA Growth

OGI (Organigram Global) YoY EBITDA Growth : 82.20% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Organigram Global YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Organigram Global's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 82.20%.

Organigram Global's EBITDA per Share for the three months ended in Dec. 2024 was $-0.02.


Organigram Global YoY EBITDA Growth Historical Data

The historical data trend for Organigram Global's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global YoY EBITDA Growth Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -74.83 -926.59 42.44 109.17 -266.36

Organigram Global Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,460.00 -271.68 900.00 104.04 82.20

Organigram Global YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Organigram Global's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (A: Sep. 2024 )
=(EBITDA per Share (A: Sep. 2024 )-EBITDA per Share (A: Aug. 2022 ))/ | EBITDA per Share (A: Aug. 2022 ) |
=(-0.183-0.11)/ | 0.11 |
=-266.36 %

Organigram Global's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.021--0.118)/ | -0.118 |
=82.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organigram Global YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Organigram Global's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.